Herpes zoster: FDA reporting patterns
56,798 FDA FAERS reports mention Herpes zoster. 35,565 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 5,318 reports
- Etanercept: 4,858 reports
- Tofacitinib: 3,659 reports
- Infliximab: 3,371 reports
- Methotrexate: 2,929 reports
- Rituximab: 2,602 reports
- Lenalidomide: 2,088 reports
- Tocilizumab: 1,746 reports
- Prednisone: 1,629 reports
- Natalizumab: 1,554 reports
- Abatacept: 1,538 reports
- Ocrelizumab: 1,452 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.